Dr. Peter Attia
speaker
5,258 appearances
36 recordings
6 series
first heard Jan 2024
last heard Jun 2025
Dr. Peter Attia’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsNo recordings in the last 12 months.Older appearances are listed below; set an alert to hear about the next one.
Appearances
They just feel more certain of it before bed, which increases worrying. So again, these are some of the techniques. I won't go through all the other stuff. There's some stuff she talks about on relaxation, which I think is helpful. And she also talked about A-B testing, other things that are probably less effective.
She wasn't a huge proponent of blocking out blue light, but she said it's always worth trying. If wearing red light or blue light glasses in the evening helps, she's like, by all means, great. Give it a shot. Obviously experimenting on timing of caffeine, medication, supplements, all great. But her view is just test those things out. So yeah, I would say those are kind of the big things.
Thank you for listening to today's sneak peek AMA episode of The Drive. If you're interested in hearing the complete version of this AMA, you'll want to become a premium member. It's extremely important to me to provide all of this content without relying on paid ads. To do this, our work is made entirely possible by our members.
And in return, we offer exclusive member-only content and benefits above and beyond what is available for free. So if you want to take your knowledge of this space to the next level, it's our goal to ensure members get back much more than the price of the subscription.
premium membership includes several benefits first comprehensive podcast show notes that detail every topic paper person and thing that we discuss in each episode and the word on the street is nobody's show notes rival ours second monthly ask me anything or ama episodes these episodes are comprised of detailed responses to subscriber questions typically focused on a single topic
and are designed to offer a great deal of clarity and detail on topics of special interest to our members. You'll also get access to the show notes for these episodes, of course. Third, delivery of our premium newsletter, which is put together by our dedicated team of research analysts.
This newsletter covers a wide range of topics related to longevity and provides much more detail than our free weekly newsletter. Fourth, access to our private podcast feed that provides you with access to every episode, including AMA's Sans the Spiel you're listening to now and in your regular podcast feed.
Fifth, The Qualies, an additional member-only podcast we put together that serves as a highlight reel featuring the best excerpts from previous episodes of The Drive. This is a great way to catch up on previous episodes without having to go back and listen to each one of them. And finally, other benefits that are added along the way.
If you want to learn more and access these member-only benefits, you can head over to peteratiamd.com forward slash subscribe. You can also find me on YouTube, Instagram, and Twitter, all with the handle peteratiamd. You can also leave us a review on Apple Podcasts or whatever podcast player you use.
This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice. No doctor-patient relationship is formed. The use of this information and the materials linked to this podcast is at the user's own risk.
The content on this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice from any medical condition they have, and they should seek the assistance of their healthcare professionals for any such conditions. Finally, I take all conflicts of interest very seriously.
For all of my disclosures and the companies I invest in or advise, please visit peteratiamd.com forward slash about where I keep an up-to-date and active list of all disclosures.
Hey everyone, welcome to The Drive Podcast. I'm your host, Peter Attia. This podcast, my website, and my weekly newsletter all focus on the goal of translating the science of longevity into something accessible for everyone. Our goal is to provide the best content in health and wellness, and we've established a great team of analysts to make this happen.
It is extremely important to me to provide all of this content without relying on paid ads. To do this, our work is made entirely possible by our members, and in return, we offer exclusive member-only content and benefits above and beyond what is available for free.
If you want to take your knowledge of this space to the next level, it's our goal to ensure members get back much more than the price of a subscription. If you want to learn more about the benefits of our premium membership, head over to peteratiamd.com forward slash subscribe. My guest this week is Dr. Susan Desmond-Hellman.
Sue is a physician who is board certified in internal medicine and medical oncology. Her impressive career has spanned multiple fields. She has been a leader in the pharmaceutical industry where she helped develop several groundbreaking drugs, worked as the chancellor of the health science campus of a major university system, UCSF, and served as the CEO of the Bill and Melinda Gates Foundation.
She also served on numerous boards of both corporations and nonprofit organizations and She co-chaired the National Academy of Science Committee that pioneered precision medicine and currently sits on the board of OpenAI.
I wanted to have Sue on this podcast to speak about her extraordinary career spanning medicine, oncology, biotech, and global health leadership, and to really explore her knowledge on how scientific innovation and leadership can drive better healthcare outcomes.
In this episode, we discuss her early days in medicine, training at UCSF during the start of the AIDS crisis before people even knew what it was, and the lessons that she learned on handling uncertainty, balancing public health messaging, and accelerating treatment breakthroughs.
The decision that she made to specialize in oncology and how her time treating HIV-related cancers in Uganda reinforced the need for integrating epidemiology patient care and policy to combat global health crises. We spoke about her transition into biotech, helping develop breakthrough cancer drugs like Taxol, Herceptin, and Avastin, and the role of precision medicine in improving outcomes.
Showing 681–700 of 5,258 · page 35 of 263
← Previous
Next →